Related Experiment Video
Updated: May 11, 2026

Development of automated imaging and analysis for zebrafish chemical screens.
Published on: June 24, 2010
The development of an in vivo γ-secretase assay using zebrafish embryos
Lachlan Wilson1, Michael Lardelli
1Discipline of Genetics, School of Molecular and Biomedical Sciences, The University of Adelaide, SA 5005, Australia. lachlan.wilson@adelaide.edu.au
Abstract:
Aberrant proteolytic processing of amyloid-β protein precursor by γ-secretase complexes may result in an imbalance between production and clearance of the Aβ proteolytic product and promote neuronal dysfunction and death. Presenilin proteins form the catalytic core of γ-secretase complexes. The zebrafish, Danio rerio, is a versatile vertebrate model for investigating the molecular basis of Alzheimer's disease pathology. It possesses genes orthologous to human PSEN1 and PSEN2 (psen1 and psen2 respectively), and AβPP (appa and appb that are duplicates of an ancestral AβPP orthologue). Currently there is no in vivo assay appropriate for directly monitoring γ-secretase activity. Here, we describe such an assay in which the level of a γ-secretase substrate (a modified form of Appa protein) is observed in zebrafish embryos by western immunoblotting relative to a co-expressed protein not subject to γ-secretase activity. We have used the assay to analyze the effects on γ-secretase activity of blocking translation of transcripts of zebrafish psen1 and/or psen2.

